Search
People

Dr Dawn Thompson

Dr Dawn Thompson
Dr Dawn Thompson
Dr Dawn Thompson

BSc, PhD

Lecturer

About
Email Address
dthompson@abdn.ac.uk
Office Address

office 6.15/lab 2.48

School of Medicine, Medical Sciences and Nutrition,

Institute of Medical Sciences,

Foresterhill, Aberdeen

ext: office:7513

School/Department
School of Medicine, Medical Sciences and Nutrition
ORCiD

Biography

I received my B.Sc Hons in Pharmacology from the University of Aberdeen before obtaining a Ph.D from the University of Strathclyde under the supervision of Prof Susan Pyne, where I studied the enzymes sphingosine kinase and sphingosine-1-phosphate phosphatase. My postdoctoral training began at the Ernest Gallo Clinic and Research Centre (University of California, San Francisco) in the laboratory of Professor Jennifer Whistler, where I investigated the consequences of disrupted GPCR trafficking in health an disease. Specifically, my work focused on the dopamine receptor family and their role in cocaine sensitisation. From here, I moved to the MRC Clinical Sciences Centre at Imperial College London followed by training at the William Harvey Research Centre at Queen Mary London in the laboratory of Profs Mauro Perretti and Roderick Flower where I studied the trafficking properties of the Formylpeptide receptor family (also GPCRs) and their role in innate immunity.  I returned to the University of Aberdeen and continued my postdoctoral studies under the supervision of Prof Mirela Delibegovic investigating the role of protein tyrosine phosphatase 1B (PTP1B) in inflammation. In January 2020 I was appointed Lecturer in Medical Sciences.     

Research

Research Overview

My research philosophy involves determining processes at the molecular level and translating these into whole animal physiology. My specific focus is G protein-coupled receptor (GPCR) regulation and the molecular mechanisms controlling GPCR endocytosis and post-endocytic fate, how these control cellular function, how disruption of these process alters cell function and ultimately how this leads to disease in the animal.  

Research Areas

Biomedical Sciences

View Research Area

Research Specialisms

  • Pharmacology
  • Neuroscience
  • Cell Biology
  • Immunology
  • Diabetes

Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.

Publications

Page 1 of 4 Results 1 to 10 of 31

  • Hydroxysteroid 17-beta dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice

    Mahmood, S., Morrice, N., Thompson, D., Milanizadeh, S., Wilson, S., Whitfield, D. P., McIlroy, G. D., Rochford, J., Mody, N.
    Experimental Physiology
    Contributions to Journals: Articles

  • Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation

    Leeson-Payne, A., Iyinikkel, J., Malcolm, C., Lam, B. Y. H., Sommer, N., Dowsett, G. K. C., Blanco Martinez de Morentin, P., Thompson, D., MacKenzie, A., Chianese, R., Kentistou, K. A., Gardner, E. J., Perry, J. R., Grassmann, F., Speakman, J., Rochford, J., Yeo, G. S. H., Murray, F., Heisler, L.
    Cell Metabolism, vol. 36, no. 5, pp. 1076-1087
    Contributions to Journals: Articles

  • A refined method of adult tissue resident stem cell derived primary human hepatic organoid cultures

    Clegg, F., Thompson, D., McLean, M. H., Murray, G., Delibegovic, M.
    Contributions to Journals: Conference Articles

  • FGF21 sensitivity in hepatocellular carcinoma could be impaired through reduction in FGFR1 and KLB expression

    Clegg, F., McLean, M. H., Thompson, D., Murray, G., Delibegovic, M.
    Contributions to Journals: Conference Articles

  • Hydroxysteroid 17-beta dehydrogenase 13(Hsd17b13)knockdown attenuates liver steatosis in high-fat diet obese mice

    Mahmood, S., Morrice, N., Thompson, D., Milanizadeh, S., Wilson, S., Whitfield, P. D., Mcilroy, G. D., Rochford, J. J., Mody, N.
    Working Papers: Preprint Papers

  • P125: Development and Evaluation of a Novel Antibody to Human FGF21

    Clegg, F., Addawiyah Imawana, R., Alnabulsi, A., McLean, M. H., Thompson, D., Delibegovic, M., Murray, G.
    Journal of Pathology, vol. 261, no. S1, pp. S63
    Contributions to Journals: Abstracts

  • Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism

    Helk, O., Dekeryte, R., Thompson, D., Kamli-Salino, S., Philip, S., Wilson, H. M., Mody, N., Delibegovic, M.
    Journal of translational medicine, vol. 21, 715
    Contributions to Journals: Articles

  • Generating a novel 3D primary human hepatic organoid model for study of metabolic diseases

    Clegg, F., Thompson, D., McLean, M. H., Murray, G., Delibegovic, M.
    Contributions to Journals: Conference Articles

  • Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice

    Thompson, D., Mahmood, S., Morrice, N., Kamli-Salino, S., Dekeryte, R., Hoffmann, P., Doherty, M. K., Whitfield, P. D., Delibegović, M., Mody, N.
    Scientific Reports, vol. 13, 3937
    Contributions to Journals: Articles

  • Using Game of Thrones to teach physiology during lockdown and beyond.

    Scott, D. A., Hislop, J., Murray, F., Thompson, D.
    Europhysiology 2022, pp. 263-264
    Contributions to Journals: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Contributions to Conferences

Contributions to Journals

Working Papers

Update